CVSA vs. NVS
CVSA (Covista Inc.) and NVS (Novartis AG) are both stocks. CVSA operates in Education & Training Services (Consumer Defensive), while NVS operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, CVSA returned 19.02%/yr vs 10.49%/yr for NVS. Their 0.19 correlation means their historical movements had little consistent relationship.
Performance
CVSA vs. NVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CVSA achieves a 20.66% return, which is significantly higher than NVS's 16.71% return. Over the past 10 years, CVSA has outperformed NVS with an annualized return of 19.02%, while NVS has yielded a comparatively lower 10.49% annualized return.
CVSA
- 1D
- -1.26%
- 1M
- -3.87%
- 6M
- 20.57%
- YTD
- 20.66%
- 1Y
- 8.78%
- 3Y*
- 42.32%
- 5Y*
- 28.00%
- 10Y*
- 19.02%
- ALL TIME*
- 14.72%
NVS
- 1D
- -1.45%
- 1M
- -2.35%
- 6M
- 8.22%
- YTD
- 16.71%
- 1Y
- 39.55%
- 3Y*
- 18.79%
- 5Y*
- 15.30%
- 10Y*
- 10.49%
- ALL TIME*
- 9.10%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
CVSA Covista Inc. | $37.87M | $44.47M | $41.94M |
NVS Novartis AG | $287.25M | $275.96M | $277.92M |
CVSA vs. NVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CVSA Covista Inc. | 20.66% | 13.89% | 54.11% | 66.06% | 20.09% | -12.93% | -2.92% | -26.10% | 12.53% | 34.78% |
NVS Novartis AG | 16.71% | 46.95% | 0.02% | 16.14% | 8.06% | -3.65% | 3.34% | 13.92% | 5.95% | 19.42% |
Correlation
The correlation between CVSA and NVS is 0.13, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.13 |
Correlation (3Y) Balances recent behavior with more history. | 0.08 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.14 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.16 |
Correlation (All Time) Calculated using the full available price history since Nov 7, 1996 | 0.19 |
The correlation between CVSA and NVS shifts across timeframes, from 0.08 (3 years) to 0.19 (all time), reflecting how their relationship changes across market environments.
Fundamentals
CVSA:
$4.25B
NVS:
$296.80B
CVSA:
$6.95
NVS:
$6.63
CVSA:
17.96
NVS:
23.56
CVSA:
0.58
NVS:
1.59
CVSA:
2.35
NVS:
5.40
CVSA:
3.18
NVS:
7.19
CVSA:
$1.91B
NVS:
$55.63B
CVSA:
$1.11B
NVS:
$41.41B
CVSA:
$431.35M
NVS:
$22.26B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CVSA vs. NVS — Risk / Return Rank
CVSA
NVS
CVSA vs. NVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Covista Inc. (CVSA) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CVSA | NVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.75 | ||
| Sortino ratioReturn per unit of downside risk | -2.13 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.33 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | 0.22 | 3.29 | -3.07 |
| Martin ratioReturn relative to average drawdown | 0.37 | 7.73 | -7.37 |
Loading charts...
Drawdowns
CVSA vs. NVS - Drawdown Comparison
The maximum CVSA drawdown since its inception was -77.26%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for CVSA and NVS.
Loading charts...
Drawdown Indicators
| CVSA | NVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.26% | -42.10% | -35.16% |
Max Drawdown (1Y)Largest decline over 1 year | -42.14% | -12.65% | -29.49% |
Max Drawdown (3Y)Largest decline over 3 years | -42.14% | -19.95% | -22.19% |
Max Drawdown (5Y)Largest decline over 5 years | -50.23% | -20.42% | -29.81% |
Max Drawdown (10Y)Largest decline over 10 years | -66.06% | -26.03% | -40.03% |
Current DrawdownCurrent decline from peak | -19.16% | -4.58% | -14.58% |
Average DrawdownAverage peak-to-trough decline | -30.63% | -10.90% | -19.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.13% | 5.38% | +19.75% |
Volatility
CVSA vs. NVS - Volatility Comparison
Covista Inc. (CVSA) has a higher volatility of 19.02% compared to Novartis AG (NVS) at 7.89%. This indicates that CVSA's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CVSA | NVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.02% | 7.89% | +11.13% |
Volatility (6M)Calculated over the trailing 6-month period | 32.90% | 16.05% | +16.85% |
Volatility (1Y)Calculated over the trailing 1-year period | 50.57% | 21.74% | +28.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.75% | 19.28% | +23.47% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.73% | 19.73% | +20.00% |
Dividends
CVSA vs. NVS - Dividend Comparison
CVSA has not paid dividends to shareholders, while NVS's dividend yield for the trailing twelve months is around 3.06%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CVSA Covista Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.15% | 1.42% |
NVS Novartis AG | 3.06% | 2.90% | 3.84% | 3.44% | 3.70% | 3.86% | 3.22% | 3.03% | 3.47% | 3.24% | 3.73% | 3.10% |
Financials
CVSA vs. NVS - Financials Comparison
This section allows you to compare key financial metrics between Covista Inc. and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CVSA vs. NVS - Profitability Comparison
CVSA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Covista Inc. reported a gross profit of 290.93M and revenue of 487.03M. Therefore, the gross margin over that period was 59.7%.
NVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Novartis AG reported a gross profit of 10.74B and revenue of 14.42B. Therefore, the gross margin over that period was 74.5%.
CVSA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Covista Inc. reported an operating income of 92.21M and revenue of 487.03M, resulting in an operating margin of 18.9%.
NVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Novartis AG reported an operating income of 4.74B and revenue of 14.42B, resulting in an operating margin of 32.8%.
CVSA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Covista Inc. reported a net income of 57.98M and revenue of 487.03M, resulting in a net margin of 11.9%.
NVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Novartis AG reported a net income of 3.27B and revenue of 14.42B, resulting in a net margin of 22.7%.
Frequently Asked Questions
CVSA and NVS have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CVSA has higher volatility (19.02%) compared to NVS (7.89%). In terms of maximum drawdown, CVSA dropped -77.26% vs NVS's -42.10%.
NVS currently has the higher Sharpe Ratio (1.93 vs 0.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CVSA and NVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer